Patent · US Expired

Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

US7799832B2 · kind B2 · utility

0Cited by

40References

11Claims

0Family size

Assignee

Valeant Pharmaceuticals North America · US

Inventors

Istvan Szelenyi · Arnstorf, DE
Kay Brune · Marloffstein, DE
Robert Hermann · Indianapolis, US
Mathias Locher · Ronneburg, DE

Key dates

Filing date	Dec 5, 2003
Grant date	Sep 21, 2010
Priority date	—
Expiry date	Feb 27, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pharmaceutical combinations of retigabine and sodium channel inhibitors for treating pains which are accompanied by an increase in muscle tone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.